Current and Upcoming Cancer Clinical Trials
Choose the Cancer Type:
Breast Cancer
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| NCIC CTG MA.32 | A Phase III Randomized Trial of Metformin versus Placebo on Recurrence
and Surviva in Early Stage Breast Cancer |
Patient Version Provider Version |
Cervical Cancer
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| GOG #240 | A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921) Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix | Patient Version Provider Version |
| GOG #263 | Randomized Phase III Clinical Trial of Adjuvant Radiation Versus Chemoradiation in Intermediate Risk, Stage I/IIA, Cervical Cancer Treated with Initial Radical Hysterectomy and Pelvic Lymphdenectomy | Patient Version Provider Version |
Endometrial Cancer
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| GOG #86-P | A Three Arm Randomized Phase II study of Paclitaxel/Carboplatin/ Bevacizumab (NSC #704865, IND #7921), Paclitaxel/Carboplatin/Temsirolimus (NSC #683864, IND#61010), and Ixabepilone (NSC#710428, IND #59699)/Carboplatin/ Bevacizumab as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer | Patient Version Provider Version |
| GOG #249 | A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma | Patient Version Provider Version |
| GOG #258 | A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma | Patient Version Provider Version |
Head and Neck
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| E1305 (ECOG) | A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients With Recurrent Or Metastatic Head and Neck Cancer | Patient Version Provider Version |
Multiple Myeloma
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| E1A06 (ECOG) | An Intergroup Phase III Randomized Controlled Trial- Comparing Melphalan, Prednisone and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed Myeloma Patients Who Are Not Candidates for High-Dose Therapy | Patient Version Provider Version |
Non-Small Cell Lung Cancer
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| E1505 (ECOG) | A randomize phase III trial of adjuvant chemotherapy with or without bevacizumab for patients completely resected stage IB (>4cm) – IIIA Non Small Cell Lung Cancer | Patient Version Provider Version |
Prevention and Control
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| 2004-0024 (MDA) | Mindfulness Study - Chemotherapy and Mindfulness Relaxation: A Randomized Trial at M.D. Anderson Cancer Center and M.D. Anderson Cancer Center Community Clinical Oncology Program | Patient Version Provider Version |
| MDA Protocol 2007-0914 |
A Multi-Center Study in Patients Undergoing Anthracycline-Based Chemotherapy to Assess the Effectiveness of Using Biomarkers to Detect and Identify Cardiotoxicity and Describe Treatment | Patient Version Provider Version |
Prostate Cancer
| Protocol (Sponsor) | Treatment Descriptions | Click Below for Details |
|---|---|---|
| E3805 (ECOG) | Phase III Randomized Study of Chemohormonal Therapy Versus Androgen Ablation Therapy in Patients With Extensive Metastatic Prostate Cancer [CHAARTED] | Patient Version Provider Version |
| CALGB 90202 | A randomized, Double-Blind, Placebo-Controlled Phase III Study of Early versus Standard Zoledronic Acid to Prevent Skeletal Related Events in Men with Prostate cancer Metastatic to Bone | Patient Version Provider Version |
